-
NMPA issued the Announcement on the Annual Report for National ADR Monitoring (2018)
2019-10-18
On October 18, 2019, NMPA issued the Announcement on the Annual Report for National ADR Monitoring (2018).
-
NMPA Issued the Technical Guidelines for Endpoints in Clinical Trials for Advanced Non-Small Cell Lung Cancer
2019-09-18
NMPA has organized the formulation of and released on September 18, 2019 the Technical Guidelines for Endpoints in Clinical Trials for Advanced Non-Small Cell Lung Cancer.
-
NMPA Issued the Announcement on Registration Application Situation and Self-Examination & Verification of Drug Clinical Trial Data
2019-10-15
On October 15, 2019, NMPA released the Announcement on Registration Application Situation and Self-Examination & Verification of Drug Clinical Trial Data with decision made to verify the clinical trial data of 7 newly received registration applications for drugs that have completed the clinical trials and are applying for production.
-
NMPA, Ministry of Public Security, National Health Commission issued the Announcement on the Inclusion of Oxycodone-Containing Compound Preparations in the Management of Psychotropic Substances
2019-08-06
NMPA,the Ministry of Public Security, and the National Health Commission decided to include oxycodone containing compound preparations in the management of psychotropic substances.
-
NMPA Issued the Notice on Enabling the New Version of the Drug Production License and other Certificates
2019-08-07
To standardize the formats and renewal of the drug administrative licenses, on August 7, 2019, NMPA issued the Notice on Enabling the New Version of the Drug Production License and other Certificates,and notified the relevant matters as follows.
-
NMPA Issued the Administrative Measures for Drug Quality Sampling Inspection
2019-08-19
NMPA issued the Administrative Measures for Drug Quality Sampling Inspection,effective as of the date of promulgation.
